Compare ThredUp Inc (TDUP) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ThredUp Inc vs Zimmer Biomet Holdings Inc — how do they compare? ThredUp Inc trades at $3.17 (market cap $405.82M), while Zimmer Biomet Holdings Inc trades at $99.52 (market cap $18.67B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 46× ThredUp Inc's market cap, and Zimmer Biomet Holdings Inc pays a 0.98% dividend while ThredUp Inc pays none. Which is the better fit depends on your goals.
| TDUP | ZBH | |
|---|---|---|
Market Cap | $405.82M | $18.67B |
Sector | Consumer Cyclical | Health |
52-Week High | $12.08 | $107.71 |
52-Week Low | $3.08 | $79.58 |
Enterprise Value | $404.00M | $25.74B |
Dividend Yield | — | 0.98% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ThredUp (TDUP) trades at $3.17, up 0.96% on the day, but remains under pressure after a significant Q2 2026 earnings miss and lowered full-year revenue guidance. The stock's technical picture is bearish, while fundamentals show improving revenue growth but persistent losses. Recent news highlights an ongoing securities investigation related to the guidance revision, contributing to negative sentiment.
The outlook is cautious. While analyst consensus is technically 'Buy' (57% of ratings), recent operational setbacks and the stock's sharp decline post-earnings suggest significant near-term risk. The primary opportunity lies in the company's high gross margins and active buyer growth, but profitability remains elusive and investor confidence is fragile.
Zimmer Biomet (ZBH) trades at $99.57, up 2.41% today, with a bullish technical signal and consistent earnings beats. Revenue grew to $8.23B in 2025, though net income margin declined to 8.56%. The stock is near resistance at $100, with a P/E of 23.76 and analyst consensus target of $103.56. Recent Q2 2026 results showed sales growth of 4.8% and an EPS beat.
Outlook is positive with raised 2026 guidance and strong institutional interest, but risks include margin pressure and high debt. Analysts are mixed with 40% buy ratings, highlighting growth in hips and robotics as key drivers. Investors should monitor execution against targets and debt management.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ThredUp Inc
ThredUp Inc is an online resale platform for women and kids apparel, shoes, and accessories. It generates revenue from items that are sold to buyers through the website, mobile app, and RaaS partners.
Read more on TDUP →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
